{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T22:01:06Z","timestamp":1648936866479},"reference-count":27,"publisher":"EDP Sciences","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Sci (Paris)"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1051\/medsci\/200420121104","type":"journal-article","created":{"date-parts":[[2011,3,5]],"date-time":"2011-03-05T10:34:27Z","timestamp":1299321267000},"page":"1104-1108","source":"Crossref","is-referenced-by-count":0,"title":["Thrombolyse et infarctus c\u00e9r\u00e9bral aigu"],"prefix":"10.1051","volume":"20","author":[{"given":"Halim","family":"Abboud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Amarenco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"250","published-online":{"date-parts":[[2004,12,15]]},"reference":[{"key":"R1","unstructured":"Larrue V, Amarenco P, Caussanel JP,et al.Recommendations for the use of intravenous thrombolytic therapy in cerebrovascular ischemic accident. French society of neurovascular disorders.Rev Neurol (Paris)2000; 156 : 1178\u201385."},{"key":"R2","doi-asserted-by":"crossref","unstructured":"The National institute of neurological disorders and stroke rt-PA stroke study group. Tissue plasminogen activator for acute ischemic stroke.N Engl J Med1995; 333 : 1581\u20137.","DOI":"10.1056\/NEJM199512143332401"},{"key":"R3","doi-asserted-by":"crossref","unstructured":"Marler JR, Tilley BC, Lu M,et al.Early stroke treatment associated with better outcome : the NINDS rt-PA stroke study.Neurology2000; 55 : 1649\u201355.","DOI":"10.1212\/WNL.55.11.1649"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Hacke W, Kaste M, Fieschi C,et al.Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European cooperative acute stroke study (ECASS).JAMA1995; 274 : 1017\u201325.","DOI":"10.1001\/jama.274.13.1017"},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Hacke W, Kaste M, Fieschi C,et al.Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second european-australasian acute stroke study investigators.Lancet1998; 352 : 1245\u201351.","DOI":"10.1016\/S0140-6736(98)08020-9"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Clark WM, Wissman S, Albers GW,et al.Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS study : a randomized controlled trial. Alteplase thrombolysis for acute noninterventional therapy in ischemic stroke.JAMA1999; 282 : 2019\u201326.","DOI":"10.1001\/jama.282.21.2019"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre acute stroke trial-Italy (MAST-I) group.Lancet1995; 346 : 1509\u201314.","DOI":"10.1016\/S0140-6736(95)92049-8"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Thrombolytic therapy with streptokinase in acute ischemic stroke. The multicenter acute stroke trial-Europe study group.N Engl J Med1996; 335 : 145\u201350.","DOI":"10.1056\/NEJM199607183350301"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"Donnan GA, Davis SM, Chambers BR,et al.Trials of streptokinase in severe acute ischaemic stroke.Lancet1995; 345 : 578\u20139.","DOI":"10.1016\/S0140-6736(95)90484-0"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Hacke W, Donnan G, Fieschi C,et al.Association of outcome with early stroke treatment : pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.Lancet2004; 363 : 768\u201374.","DOI":"10.1016\/S0140-6736(04)15692-4"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Wardlaw JM, Warlow CP, Counsell C. Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke.Lancet1997; 350 : 607\u201314.","DOI":"10.1016\/S0140-6736(97)03022-5"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"Molina CA, Montaner J, Abilleira S,et al.Timing of spontaneous recanalization and risk of hemorrhagic transformation in acute cardioembolic stroke.Stroke2001; 32 : 1079\u201384.","DOI":"10.1161\/01.STR.32.5.1079"},{"key":"R13","doi-asserted-by":"crossref","unstructured":"Larrue V, von Kummer RR, Muller A, Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator : a secondary analysis of the European-Australasian acute stroke study (ECASS II).Stroke2001; 32 : 438\u201341.","DOI":"10.1161\/01.STR.32.2.438"},{"key":"R14","doi-asserted-by":"crossref","unstructured":"Selim M, Fink JN, Kumar S,et al.Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator : prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume.Stroke2002; 33 : 2047\u201352.","DOI":"10.1161\/01.STR.0000023577.65990.4E"},{"key":"R15","doi-asserted-by":"crossref","unstructured":"Knight RA, Dereski MO, Helpern JA,et al.Magnetic resonance imaging assessment of evolving focal cerebral ischemia. Comparison with histopathology in rats.Stroke1994; 25 : 1252\u201362.","DOI":"10.1161\/01.STR.25.6.1252"},{"key":"R16","unstructured":"Miyasaka N, Nagaoka T, Kuroiwa T,et al.Histopathologic correlates of temporal diffusion changes in a rat model of cerebral hypoxia\/ischemia.Am J Neuroradiol2000; 21 : 60\u20136."},{"key":"R17","doi-asserted-by":"crossref","unstructured":"Del Zoppo GJ, von Kummer R, Hamann GF. Ischaemic damage of brain microvessels : inherent risks for thrombolytic treatment in stroke.J Neurol Neurosurg Psychiatry1998; 65 : 1\u20139.","DOI":"10.1136\/jnnp.65.1.1"},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Dijkhuizen RM, Asahi M, Wu O,et al.Delayed rt-PA treatment in a rat embolic stroke model : diagnosis and prognosis of ischemic injury and hemorrhagic transformation with magnetic resonance imaging.J Cereb Blood Flow Metab2001; 21 : 964\u201371.","DOI":"10.1097\/00004647-200108000-00009"},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Ueda T, Hatakeyama T, Kumon Y,et al.Evaluation of risk of hemorrhagic transformation in local intra-arterial thrombolysis in acute ischemic stroke by initial SPECT.Stroke1994; 25 : 298\u2013303.","DOI":"10.1161\/01.STR.25.2.298"},{"key":"R20","unstructured":"Shimosegawa E, Hatazawa J, Inugami A,et al.Cerebral infarction within six hours of onset : prediction of completed infarction with technetium-99m-HMPAO SPECT.J Nucl Med1994; 35 : 1097\u2013103."},{"key":"R21","doi-asserted-by":"crossref","unstructured":"Del Zoppo GJ, Poeck K, Pessin MS,et al.Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke.Ann Neurol1992; 32 : 78\u201386.","DOI":"10.1002\/ana.410320113"},{"key":"R22","doi-asserted-by":"crossref","unstructured":"Mori E, Yoneda Y, Tabuchi M,et al.Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke.Neurology1992; 42 : 976\u201382.","DOI":"10.1212\/WNL.42.5.976"},{"key":"R23","doi-asserted-by":"crossref","unstructured":"Alexandrov AV, Grotta JC. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator.Neurology2002; 59 : 862\u20137.","DOI":"10.1212\/WNL.59.6.862"},{"key":"R24","doi-asserted-by":"crossref","unstructured":"Furlan A, Higashida R, Wechsler L,et al.Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study : a randomized controlled trial. Prolyse in acute cerebral thromboembolism.JAMA1999; 282 : 2003\u201311.","DOI":"10.1001\/jama.282.21.2003"},{"key":"R25","doi-asserted-by":"crossref","unstructured":"Hacke W, Warach S. Diffusion-weighted MRI as an evolving standard of care in acute stroke.Neurology2000; 54 : 1548\u20139.","DOI":"10.1212\/WNL.54.8.1548"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Parsons MW, Barber PA, Chalk J,et al.Diffusion and perfusion-weighted MRI response to thrombolysis in stroke.Ann Neurol2002; 51 : 28\u201337.","DOI":"10.1002\/ana.10067"},{"key":"R27","doi-asserted-by":"crossref","unstructured":"Kidwell CS, Saver JL, Mattiello J,et al.Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion\/perfusion magnetic resonance imaging.Ann Neurol2000; 47 : 462\u20139.","DOI":"10.1002\/1531-8249(200004)47:4<462::AID-ANA9>3.3.CO;2-P"}],"container-title":["m\u00e9decine\/sciences"],"original-title":[],"link":[{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/200420121104\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T21:33:04Z","timestamp":1560029584000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/200420121104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":27,"journal-issue":{"issue":"12"},"alternative-id":["medsci20042012p1104"],"URL":"https:\/\/doi.org\/10.1051\/medsci\/200420121104","relation":{},"ISSN":["0767-0974","1958-5381"],"issn-type":[{"value":"0767-0974","type":"print"},{"value":"1958-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}